RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 173 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $407,520 | +1644.9% | 9,925 | +1741.4% | 0.01% | +600.0% |
| Q1 2024 | $23,355 | -94.8% | 539 | -94.4% | 0.00% | -83.3% |
| Q4 2023 | $446,277 | +1962.1% | 9,708 | +928.4% | 0.01% | +500.0% |
| Q3 2023 | $21,642 | -65.0% | 944 | -74.8% | 0.00% | -50.0% |
| Q2 2023 | $61,838 | +20042.7% | 3,750 | -78.2% | 0.00% | -80.0% |
| Q1 2023 | $307 | -23.2% | 17,213 | +25.2% | 0.01% | -41.2% |
| Q4 2022 | $400 | -99.8% | 13,750 | +62.3% | 0.02% | +466.7% |
| Q3 2022 | $207,000 | +728.0% | 8,474 | +46.0% | 0.00% | +200.0% |
| Q2 2022 | $25,000 | -93.7% | 5,804 | -83.2% | 0.00% | -75.0% |
| Q1 2022 | $397,000 | +1488.0% | 34,508 | +1270.5% | 0.00% | – |
| Q4 2021 | $25,000 | -39.0% | 2,518 | -21.2% | 0.00% | -100.0% |
| Q3 2021 | $41,000 | -43.8% | 3,197 | -14.4% | 0.00% | -50.0% |
| Q2 2021 | $73,000 | +52.1% | 3,735 | +64.2% | 0.00% | +100.0% |
| Q1 2021 | $48,000 | +108.7% | 2,274 | +190.1% | 0.00% | 0.0% |
| Q4 2020 | $23,000 | -47.7% | 784 | -61.1% | 0.00% | – |
| Q3 2020 | $44,000 | -29.0% | 2,017 | -27.6% | 0.00% | -100.0% |
| Q2 2020 | $62,000 | +376.9% | 2,784 | +361.7% | 0.00% | +200.0% |
| Q3 2019 | $13,000 | -56.7% | 603 | -44.9% | 0.00% | -50.0% |
| Q1 2019 | $30,000 | +328.6% | 1,095 | +364.0% | 0.00% | +100.0% |
| Q4 2018 | $7,000 | +600.0% | 236 | +381.6% | 0.00% | – |
| Q3 2018 | $1,000 | -92.3% | 49 | -88.4% | 0.00% | -100.0% |
| Q2 2018 | $13,000 | +62.5% | 424 | +8.2% | 0.00% | 0.0% |
| Q1 2018 | $8,000 | – | 392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 735,000 | $13,112,400 | 3.93% |
| NEA Management Company, LLC | 2,909,956 | $51,913,615 | 3.59% |
| Frazier Life Sciences Management, L.P. | 2,164,739 | $38,618,944 | 2.80% |
| RA Capital Management | 5,516,067 | $98,406,635 | 2.23% |
| Samsara BioCapital, LLC | 345,293 | $6,160,027 | 1.27% |
| Rock Springs Capital Management LP | 1,597,123 | $28,492,674 | 0.68% |
| Baker Brothers Advisors | 6,498,267 | $115,929,083 | 0.63% |
| HighVista Strategies LLC | 35,478 | $632,928 | 0.52% |
| Nan Fung Group Holdings Ltd | 32,520 | $580,157 | 0.40% |
| GREAT POINT PARTNERS LLC | 97,544 | $1,740,185 | 0.34% |